NCT03094520 (GEST) is a NA clinical trial of tDCS in Healthy Young Adults, sponsored by Charite University, Berlin, Germany.

Who is sponsoring NCT03094520?

NCT03094520 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT03094520?

Interventions in NCT03094520: tDCS, sham-tDCS.

What condition does NCT03094520 study?

NCT03094520 studies Healthy Young Adults.

Is NCT03094520 still recruiting?

NCT03094520 is currently completed. Last updated 11 May 2021.

Last reviewed 2021-05-11 · How we verify

NCT03094520: GEST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Embodiment Activation by tDCS

Completed NA Last updated 11 May 2021

What this trial tests

NA trial testing tDCS in Healthy Young Adults in 22 participants. Completed in 1 October 2018.

Timeline

1 May 2016

Primary endpoint
1 May 2018

1 October 2018

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	22
Start date	1 May 2016
Primary completion	1 May 2018
Estimated completion	1 October 2018
Sites	1 location across Germany

Drugs / interventions tested

tDCS — full drug profile →
sham-tDCS

Conditions studied

Healthy Young Adults — all drugs for Healthy Young Adults →

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 18 to 30, any sex, with Healthy Young Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the proposed research is to extend our understanding of how gesture and language interact, focusing on the role of cognitive embodiment in this interaction, and to explore the neural systems that support links between language and actions systems.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of tDCS

Trials testing the same drug.

NCT07400939 — Brain Stimulation Combined With Watching Hand Movements to Improve Hand Recovery in Chronic Stroke · NA · recruiting
NCT06994390 — Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial) · NA · not yet recruiting
NCT07358832 — Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease · NA · recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT06972368 — Home-Based tDCS for Depression in BPD · NA · recruiting

Other recruiting trials for Healthy Young Adults

Currently open trials in the same condition.

NCT07496866 — Music Induced Modulation of Pressure Pain Sensitivity and Affective Valence, Comparing Silence and Self-Selected Levanti · NA · active not recruiting
NCT07197346 — Repetitive Transcranial Magnetic Stimulation Primed Self-controlled Practice on Motor Learning · NA · recruiting
NCT07515417 — Effect of Magnesium Supplementation on Sleep Quality and Cognitive Function in Saudi Adults · NA · active not recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03094520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 11 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03094520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing